Roundhill Investments - G... (OZEM)
NASDAQ: OZEM
· Real-Time Price · USD
27.32
0.56 (2.10%)
At close: Sep 30, 2025, 3:59 PM
27.72
1.45%
After-hours: Sep 30, 2025, 05:00 PM EDT
2.10% (1D)
| Bid | 26.6 |
| Market Cap | 35.1M |
| AUM | 33.45M |
| NAV | 26.55 |
| EPS (ttm) | 1.28 |
| PE Ratio (ttm) | 21.41 |
| Shares Out | 1.28M |
| Inception Date | May 21, 2024 |
| Ask | 27.73 |
| Volume | 6,937 |
| Open | 26.61 |
| Previous Close | 26.76 |
| Day's Range | 26.56 - 27.36 |
| 52-Week Range | 20.01 - 29.21 |
| Holdings | 29 |
| Expense Ratio | 0.59% |
About OZEM
Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Asset Class Equity
Ticker Symbol OZEM
Inception Date May 21, 2024
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 61.81% of assets
| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/s | NVO | 17.84% |
| Eli Lilly And Compan... | LLY | 14.79% |
| Viking Therapeutics,... | VKTX | 4.52% |
| Structure Therapeuti... | GPCR | 4.34% |
| Metsera, Inc. | MTSR | 3.99% |
| Pfizer Inc. | PFE | 3.80% |
| Amgen Inc. | AMGN | 3.46% |
| Astrazeneca PLC | AZN | 3.38% |
| Regeneron Pharmaceut... | REGN | 2.87% |
| Scholar Rock Holding... | SRRK | 2.82% |
Dividends Dividend Yield 0.22%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
